Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times

Francisco J Vizoso; Silvia Fernández-Francos; Noemi Eiro

doi:10.3390/ijms22168395

Mesenchymal Stem/Stromal Cells and Their Derivates in Acute Diseases: Emergency in the Post-COVID-19 Times

Int J Mol Sci. 2021 Aug 5;22(16):8395. doi: 10.3390/ijms22168395.

Authors

Francisco J Vizoso^{1

2}, Silvia Fernández-Francos^{1

3}, Noemi Eiro¹

Affiliations

¹ Research Unit, Fundación Hospital de Jove, Av. Eduardo Castro, 161, 33290 Gijón, Spain.
² Department of Surgery, Fundación Hospital de Jove, Av. Eduardo Castro, 161, 33290 Gijón, Spain.
³ Department of Anesthesiology, Fundación Hospital de Jove, Av. Eduardo Castro, 161, 33290 Gijón, Spain.

Abstract

The current coronavirus disease-19 (COVID-19) pandemic has strongly revived the pressing need to incorporate new therapeutic alternatives to deal with medical situations that result in a dramatic breakdown in the body's normal homeostasis [...].

Keywords: acute diseases; exosomes; extracellular vesicles; mesenchymal stem cells.

Publication types

Editorial

MeSH terms

Acute Disease / mortality
Acute Disease / therapy*
COVID-19 / mortality
COVID-19 / therapy*
Clinical Trials as Topic
Emergency Service, Hospital
Emergency Treatment / methods*
Emergency Treatment / trends
Humans
Mesenchymal Stem Cell Transplantation / methods*
Mesenchymal Stem Cell Transplantation / trends
Regenerative Medicine / methods*
Regenerative Medicine / trends
Survival Rate
Treatment Outcome